As Omicron rages across India, causing a spike in COVID-19 cases, Pune's Gennova Biopharmaceuticals is developing an Omicron-specific vaccine.

The company, according to a spokesperson, has already filed its phase 2 data with Central Drugs Standard Control Organisation (CDSCO). "Gennova Biopharmaceuticals had filed its phase 2 data with CDSCO on Friday. The Omicron specific variant of vaccine is under development and will be ready for human clinical trials, subject to regulatory approvals," news agency ANI quoted the spokesperson of Gennova Biopharmaceuticals as saying.

Here’s what we know so far about this new vaccine.
Read more at https://www.firstpost.com/health/pune-based-gennova-biopharmaceutic...